Genfit S.A. (EPA:GNFT)
France
· Delayed Price · Currency is EUR 8.09
-0.04 (-0.49%)
Apr 28, 2026, 5:35 PM CET
Genfit Employees
Genfit had 180 employees as of December 31, 2024. The number of employees increased by 21 or 13.21% compared to the previous year.
Employees
180
Change (1Y)
21
Growth (1Y)
13.21%
Revenue / Employee
€348,048
Profits / Employee
€457,277
Market Cap
402.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Transgene | 145 |
| Sensorion | 63 |
| MedinCell | 145 |
| Inventiva | 77 |
| DBV Technologies | 117 |
| ABIONYX Pharma | 51 |
Genfit News
- 8 days ago - GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025) - GlobeNewsWire
- 26 days ago - GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Earnings To Watch: Genfit SA (XPAR:GNFT) Reports Q4 2025 Result - GuruFocus
- 7 weeks ago - GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF - GlobeNewsWire
- 2 months ago - GENFIT to receive US$20M milestone after Ipsen's Iqirvo® exceeds the US$200M threshold in its first full year of net sales - GlobeNewsWire
- 3 months ago - GENFIT Announces 2026 Financial Calendar - GlobeNewsWire
- 4 months ago - GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy - GlobeNewsWire
- 5 months ago - GENFIT Announces Appointment of new Chief Medical Officer - GlobeNewsWire